Virtual AML Round Table with MD Anderson on October 8th image

Virtual AML Round Table with MD Anderson on October 8th

Oct 08, 2022
11:00AM - 01:30PM CDT
Online Event
Overview

This event will take place at 9 AM PACIFIC, 10 AM MOUNTAIN, 11 AM CENTRAL & 12 NOON EASTERN

Our agenda will cover the following topics:

The MD Anderson Treatment Approach To:

• Treatment in Younger and Older Patients 
• Maintenance Therapy
• Evaluating MRD Status
• Stem Cell Transplantation
• New and Emerging Therapies
• Supportive Care During Treatment

MD Anderson AML expert panel: 

  • Naval Daver, MD - Director, Department of Leukemia
  • Nicholas Short, MD - Assistant Professor, Department of Leukemia
  • Tapan Kadia, MD - Assistant Professor, Department of Leukemia
  • Betul Oran, MD - Associate Professor, Department of Stem Cell Transplantation
  • Samantha Salvatora, PA-C - Physician Assistant, Department of Leukemia
  • Alexa Probst, MS, PA-C - Supervisor, Advanced Practice Providers, Department of Leukemia

 

Thank You To Our Round Table Sponsors:

User uploaded media

What are HealthTree Round Tables for AML?

These events are education programs for AML patients and caregivers on a variety of treatment and research issues. Each Round Table features presentations from internationally-recognized AML experts who will also participate in extensive Q&A time with audience members. In 2022, these events will take place either in-person at a variety of US-based locations or virtually.

Agenda
11:00 AM
Welcome & Introduction
Kerith Amen
Kerith introduces the agenda for the event and the featured speakers.
11:05 AM
AML Treatment in Younger and Older Patients & Maintenance Therapy
Tapan Kadia, MD
Dr. Kadia will discuss the the treatment of AML in younger patients/suitable for intensive chemotherapy, treatment of AML in older patients not suitable for intensive chemotherapy as well as maintenance therapy in AML patients.
11:25 AM
Evaluating MRD Status
Nicholas Short, MD
Dr. Short will share what Measurable Residual Disease is and how it being used at MD Anderson.
11:45 AM
Stem Cell Transplantation
Betul Oran, MD
Dr. Oran will discuss the basics of stem cell transplantation in AML, when to transplant and the transplant approach at MD Anderson.
12:05 PM
New & Emerging AML Therapies
Naval Daver, MD
Dr. Daver will share his knowledge about when to consider novel therapies in treatment and the latest clinical trials in AML.
12:25 PM
Q&A Session
Audience
Audience can type their questions in the Q&A area and the expert panel will answer them!
12:45 PM
Supportive Care During Treatment
Samantha Salvatora, PA-C
Samantha Salvatora and Alexa Probst will cover the topic of supportive care which will include expectations during treatment and the prevention/management of side effects.
01:00 PM
Supportive Care During Treatment
Alexa Probst, MS, PA-C
Samantha Salvatore and Alexa Probst will cover the topic of supportive care which will include expectations during treatment and the prevention/management of side effects.
01:15 PM
Q&A Session
Audience
Audience can type their questions in the Q&A area and the expert panel will answer them!
Speakers & Moderators
Healthtree contact Tapan Kadia, MD

Tapan Kadia, MD

Hematologist Oncologist, Assistant Professor in the Department of Leukemia at The University of Texas MD Anderson Cancer Center
Healthtree contact Nicholas Short, MD

Nicholas Short, MD

Hematologist Oncologist, Assistant Professor in the Department of Leukemia at The University of Texas MD Anderson Cancer Center
Healthtree contact Betul Oran, MD

Betul Oran, MD

Professor in the Department of Stem Cell Transplantation at The University of Texas MD Anderson Cancer Center
Healthtree contact Naval Daver, MD

Naval Daver, MD

Dr. Naval Daver is an Associate Professor in the Department of Leukemia at MD Anderson Cancer Center at the University of Texas. He completed his medical school from Grant Medical College and Sir J group of Hospitals Mumbai, followed by a residency and fellowship in hematology-oncology from Baylor College of Medicine. He is a clinical investigator with a focus on molecular and immune therapies in AML and Myelofibrosis and is principal investigator on over 25 ongoing institutional, national and international clinical trials in these diseases. He is especially interested in developing monoclonal and bispecific antibodies, immune checkpoint and vaccine based approaches in AML, MDS, and myelofibrosis and is leading a number of these trials at MD Anderson Cancer Center.
Healthtree contact Samantha Salvatora, PA-C

Samantha Salvatora, PA-C

Physician Assistant, Department of Leukemia at MD Anderson Cancer Center at the University of Texas
Healthtree contact Alexa Probst, MS, PA-C

Alexa Probst, MS, PA-C

Supervisor, Advanced Practice Providers - Department of Leukemia at MD Anderson Cancer Center at the University of Texas
Healthtree contact Kerith Amen

Kerith Amen

Kerith joined HealthTree Foundation as a Community Co-Director for AML in 2022. She is a mother to a spirited eight-year-old daughter, Adair, and their beloved rescue, Violet. She lost her best friend and husband, Rob, to AML in March 2018. Kerith wishes she had a resource such as HealthTree for AML during Rob’s illness. She is a strong supporter of HealthTree's mission. She hopes that by sharing her experience, she may help other patients and caregivers navigate an AML diagnosis.